Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury
Clinical trial NCT05016011 · COMPLETED
Trial details
- NCT number
- NCT05016011
- Sponsor
- Cytopeutics Sdn. Bhd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2022-03-21
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.